Literature DB >> 18423974

Antibiotic prophylaxis in urologic procedures: a systematic review.

A M Jikke Bootsma1, M Pilar Laguna Pes, Suzanne E Geerlings, Astrid Goossens.   

Abstract

OBJECTIVE: Antibiotic prophylaxis is used to minimize infectious complications resulting from interventions. Side-effects and development of microbial resistance patterns are risks of the use of antibiotics. Therefore, the use should be well considered and based on high levels of evidence. In this review, all available evidence on the use of antibiotic prophylaxis in urology is gathered, assessed, and presented in order to make choices in the use of antibiotic prophylaxis on the best evidence currently available.
METHODS: A systematic literature review was conducted, searching Medline, Embase (1980-2006), the Cochrane Library, and reference lists for relevant studies. All selected articles were reviewed independently by two, and, in case of discordance, three, reviewers.
RESULTS: Only the transurethral resection of prostate (TURP) and prostate biopsy are well studied and have a high and moderate to high level of evidence in favour of using antibiotic prophylaxis. Other urologic interventions are not well studied. The moderate to low evidence suggests no need for antibiotic prophylaxis in cystoscopy, urodynamic investigation, transurethral resection of bladder tumor, and extracorporeal shock-wave lithotripsy, whereas for therapeutic ureterorenoscopy and percutaneous nephrolithotomy, the low evidence favours the use of antibiotic prophylaxis. Urologic open and laparoscopic interventions were classified according to surgical wound classification, since no studies were identified. Antibiotic prophylaxis is not advised in clean surgery, but is advised in clean-contaminated and prosthetic surgery.
CONCLUSIONS: Except for the TURP and prostate biopsy, there is a lack of well-performed studies investigating the need for antibiotic prophylaxis in urologic interventions.

Entities:  

Mesh:

Year:  2008        PMID: 18423974     DOI: 10.1016/j.eururo.2008.03.033

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  45 in total

Review 1.  Asymptomatic bacteriuria: when the treatment is worse than the disease.

Authors:  Barbara W Trautner
Journal:  Nat Rev Urol       Date:  2011-12-06       Impact factor: 14.432

2.  Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections.

Authors:  P Rattanaumpawan; P Tolomeo; W B Bilker; N O Fishman; E Lautenbach
Journal:  J Hosp Infect       Date:  2010-12       Impact factor: 3.926

Review 3.  [Prostate biopsy: Procedure in the clinical routine].

Authors:  T Enzmann; T Tokas; K Korte; M Ritter; P Hammerer; L Franzaring; H Heynemann; H-W Gottfried; H Bertermann; M Meyer-Schwickerath; B Wirth; A Pelzer; T Loch
Journal:  Urologe A       Date:  2015-12       Impact factor: 0.639

4.  [Infection and sepsis prevention in prostate biopsy].

Authors:  F M E Wagenlehner; A Pilatz; P Waliszewski; T Dansranjavin; W Weidner
Journal:  Urologe A       Date:  2013-10       Impact factor: 0.639

5.  [Transrectal prostate biopsy: effective anesthesia, complications, and influence on clinical outcome after radical prostatectomy].

Authors:  G Müller; H Borrusch; I Knop; U Otto
Journal:  Urologe A       Date:  2011-04       Impact factor: 0.639

6.  [Antibiotic prophylaxis for endourological interventions considering antibiotic stewardship].

Authors:  Jennifer Kranz; Laila Schneidewind; Adrian Pilatz; Flo Ri An Wagenlehner
Journal:  Urologe A       Date:  2021-02-09       Impact factor: 0.639

Review 7.  Antibiotic use and the prevention and management of infectious complications in stone disease.

Authors:  Daniel A Wollin; Adrian D Joyce; Mantu Gupta; Michael Y C Wong; Pilar Laguna; Stavros Gravas; Jorge Gutierrez; Luigi Cormio; Kunjie Wang; Glenn M Preminger
Journal:  World J Urol       Date:  2017-02-03       Impact factor: 4.226

8.  Comparison of three different antibiotic protocols in transurethral resection of bladder tumour and the possible infectious risk factors: A non-randomized, prospective study.

Authors:  Jorge Panach-Navarrete; Lorena Valls-González; Eduardo Sánchez-Cano; María Medina-González; Ana Castelló-Porcar; José María Martínez-Jabaloyas
Journal:  Can Urol Assoc J       Date:  2018-06-08       Impact factor: 1.862

9.  Prevention and treatment of septic shock following mini-percutaneous nephrolithotomy: a single-center retrospective study of 834 cases.

Authors:  Chunlai Liu; Xiling Zhang; Yili Liu; Ping Wang
Journal:  World J Urol       Date:  2012-12-18       Impact factor: 4.226

10.  A single dose of meropenem is superior to ciprofloxacin in preventing infections after transrectal ultrasound-guided prostate biopsies in the era of quinolone resistance.

Authors:  Michael Samarinas; Konstantinos Dimitropoulos; Ioannis Zachos; Stavros Gravas; Anastasios Karatzas; Vasileios Tzortzis
Journal:  World J Urol       Date:  2016-03-07       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.